Xiwei Wu

10PUBLICATIONS
105CO-AUTHORS
Molecular targetsMetals and alloy materialsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 26, 2025
Developmental control of DNA damage responses in α- and β-cells shapes the selective beta-cell susceptibility in diabetes.

Sneha S Varghese, Alessandro Giovanni Hernandez-De La Peña, Aparamita Pandey

|Apr 24, 2025
Distinct adipose progenitor cells emerging with age drive active adipogenesis.

Guan Wang, Gaoyan Li, Anying Song

|Feb 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.

Christiane Querfeld, Joycelynne Palmer, Zhen Han

|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

Zhuo Chen, Eiichiro Satake, Marcus G Pezzolesi

|Feb 26, 2024
Critical Differential Expression Assessment for Individual Bulk RNA-Seq Projects.

Charles D Warden, Xiwei Wu

|Oct 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer.

Atish Mohanty, Arin Nam, Saumya Srivastava

Pageof 2

Frequent Collaborators

3 joint publications

Hanjun Qin

2 joint publications

Zhaohui Gu

2 joint publications

Charles D Warden

2 joint publications

Guido Marcucci